Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Anavex Life Sciences Corp AVXL

Anavex Life Sciences Corp. is a clinical-stage biopharmaceutical company. The Company is engaged in the development of differentiated therapeutics by applying precision medicine to central nervous system (CNS) diseases with unmet need. The Company analyzes genomic data from clinical trials to identify biomarkers, which are used in the analysis of its clinical trials for the treatment of... see more

NDAQ:AVXL - Post Discussion

Anavex Life Sciences Corp > End of First Half - 2020
View:
Post by R_J_ on Jul 01, 2020 5:21am

End of First Half - 2020

End of the First Half Report for 2020 for Anavex Life Sciences Corp.
-
AVXL closed on 06/30/2020 at US$4.92
AVXL closed on 12/31/2019 at US$2.59
-
This is a 90.0%, a US$2.33, GAIN for the first half of 2020.
-
S&P 500 Index for first half of 2020.  
                 
Closed on 2020/06/30 @ 3100.2            
Closed on 2019/12/31 @ 3230.7                    
This is a loss for the 1st Half of 4.0%, or 130.4
Its MA(200) ended the 1st Half @ 3021.6
-
Two Hundred Day Moving Average [MA(200)] stuff.
AVXL's  MA(200) ended June at $3.30
AVXL is now 49.1% above its MA(200).
-
Who is the Big Cheese at AVXL?
Christopher U. Missling, PhD, President & CEO
-
RJ
Be the first to comment on this post
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities